Survival analysis of the TCGA BC cohort stratified by SIRT1 mRNA levels revealed that patients with low SIRT1 mRNA levels had shorter overall survival compared to those with high SIRT1 mRNA levels, highlighting the tumor suppressor role of SIRT1 in breast cancer (Fig. S3D, Supporting Information). This evidence concerns the gene SIRT1 and breast carcinoma.